AstraZeneca PLC (AZN)
NASDAQ: AZN · IEX Real-Time Price · USD
79.18
+2.07 (2.68%)
At close: May 21, 2024, 4:00 PM
79.08
-0.10 (-0.13%)
After-hours: May 21, 2024, 6:12 PM EDT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $245.50 billion as of May 21, 2024. Its market cap has increased by 6.04% in one year.
Market Cap
245.50B
Enterprise Value
270.66B
1-Year Change
6.04%
Ranking
Category
Stock Price
$79.18
Market Cap Chart
Since November 21, 2000, AstraZeneca's market cap has increased from $63.18B to $245.50B, an increase of 288.59%. That is a compound annual growth rate of 5.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 20, 2024 | 239.07B | 0.27% |
May 17, 2024 | 238.42B | -0.18% |
May 16, 2024 | 238.85B | 0.09% |
May 15, 2024 | 238.63B | -0.09% |
May 14, 2024 | 238.85B | -0.50% |
May 13, 2024 | 240.06B | 0.32% |
May 10, 2024 | 239.28B | -0.55% |
May 9, 2024 | 240.62B | 0.83% |
May 8, 2024 | 238.63B | 0.85% |
May 7, 2024 | 236.62B | 0.74% |
May 6, 2024 | 234.88B | -0.77% |
May 3, 2024 | 236.71B | 0.73% |
May 2, 2024 | 235.00B | -0.80% |
May 1, 2024 | 236.90B | 0.70% |
Apr 30, 2024 | 235.25B | 0.53% |
Apr 29, 2024 | 234.01B | 0.41% |
Apr 26, 2024 | 233.05B | 0.19% |
Apr 25, 2024 | 232.62B | 5.38% |
Apr 24, 2024 | 220.74B | 0.49% |
Apr 23, 2024 | 219.66B | 1.03% |
Apr 22, 2024 | 217.43B | 2.30% |
Apr 19, 2024 | 212.53B | 0.28% |
Apr 18, 2024 | 211.94B | -0.25% |
Apr 17, 2024 | 212.47B | 0.39% |
Apr 16, 2024 | 211.64B | -0.68% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Novo Nordisk | 586.51B |
UnitedHealth Group | 476.05B |
Johnson & Johnson | 364.06B |
Merck & Co. | 331.77B |
AbbVie | 290.59B |
Thermo Fisher | 226.74B |
Novartis AG | 201.21B |
Danaher | 197.84B |